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When  Kendall,  Heidelberger,  and Dawson  (1) isolated a polysaccharide
from group A hemolytic  streptococcus cultures, they gave renewed interest
to  the  subject  of  streptococcus  capsules.  Somewhat  later,  Seastone  (2)
showed  that the capsules  of  group  C  streptococci  were  chemically  similar
to those of group A.  In both groups, this capsular polysaccharide  is non-
type-specific;  with  heat-killed  vaccines  prepared  from  both  group  A  and
group  C strains, it has been impossible  to stimulate in  rabbits the produc-
tion of any antibodies against this capsular  substance.  A further interest-
ing fact is that a chemically similar substance occurs widely throughout the
mammalian organism,  and has been isolated by Meyer and his collaborators
from vitreous humor,  Wharton's jelly, synovial  fluid,  and the fluid  from a
mesothelial  tumor  (3-5).  Moreover,  enzymes  capable  of  splitting  this
polysaccharide  occur in certain bacteria  (6,  7) and also in some mammalian
tissues  (8,  7).
All of the above facts raise interesting questions concerning  the  role  of
the capsule in infection with streptococci.  How may a capsule, made up of
a  substance  normally  present  in  the  host,  influence  the pathogenesis  and
virulence  of an invading  streptococcus?  It  is with this  question  that the
present  paper  is  principally  concerned.
Preparation  of the Capsular  Polysaccharide
Kendall,  Heidelberger,  and  Dawson  obtained  the  polysaccharide  from
the  supernatant  fluids of broth cultures  of  group  A streptococci  following
centrifugation.  Upon  repeating  their  work,  we  found  that  all  of  our
preparations contained about 50 per cent of blood group A substance.  This
contaminating material has been shown to be present in large quantities in
peptone  (9).  In order  to eliminate this and other  sources of error, all the
media, before they were used for culture,  were prepared  as follows:-
The medium was  essentially  that  of Todd and Hewitt  (10)  except that beef heart
or  vegex  was  substituted  for  the  horse  meat,  and  the alcohol-insoluble  fraction  was
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removed before  use.  The beef heart infusion for 60 liters  of medium  was first  concen-
trated in vacuo to 4 liters; when vegex  was used  600 gm. of the paste was dissolved in
4 liters  of water.  In this concentrate  1,500 gm. of  Pfanstiehl  peptone was  dissolved,
then 2.5 volumes  of ethyl alcohol was added.  The precipitate which  settled out over-
night  was  discarded;  and  the  alcohol  in  the  supernatant  fluid  was  removed  by  dis-
tillation in  vacuo.  This material was then dissolved in 60 liters of tap water; the pH was
adjusted to 7.4; and the salt mixture  was added,  bringing the final pH to  7.8.  It  was
then filtered through Chamberland filters No. L 5 and inoculated immediately by adding
100  cc. of young actively growing culture to each 4 liter flask.  The growth was always
heavy.  After overnight incubation, the organisms were killed by adding either formalin
or acetic acid to a final concentration  of 2 per cent.  The microorganisms  were removed
by  centrifugation  in  a  Sharples  supercentrifuge;  and the  clear  supernatant  fluid  was
concentrated  in  vacuo  to  one-tenth  the  original  volume.  To  this  concentrate  were
added 0.1  volume  of  glacial  acetic acid,  500 gm.  of sodium acetate,  and  1.25 volumes
of ethyl  alcohol.  The  precipitate  which  formed  was  redissolved  in  2  liters  of water
containing  acetic acid and sodium  acetate  as before, and again precipitated  with  1.25
TABLE  I
Analyses of Carbohydrate  Capsular Preparations  from Group A  Hemolytic Streptococci
Lot No.  Strain  Type  S  Total N  Total C  Acetyl  Ash
per cent  per cent  per cent  per Ct
90  S23  14  -60.2  3.30  42.8  11.50  1.80
91  S43  6  -61.7  3.55  42.7  12.12  1.78
92  S23  14  -66.1  3.16  44.7  10.70  1.58
volumes  of  ethyl  alcohol.  The  precipitate,  already  fairly  free  of  protein,  was  again
dissolved in water  and shaken  with  chloroform and butyl alcohol  (11)  until a precipi-
tate  no longer  formed at  the  interface.  After  a third precipitation  with  alcohol,  the
polysaccharide  was dissolved  in water and  dialyzed  1 or 2 days against  distilled  water.
The  fourth  and final  precipitation  was in  10  volumes  of  cold acetone,  after  adding  a
drop  of  HC1  to  the  carbohydrate  solution.  This  precipitate  was  washed  in  acetone
and  dried in vacuo.  The final yield, at best about  120 mg. per liter of original culture,
varied considerably among the different microorganisms used.
In Table I are shown certain chemical data on preparations  made in the
above  manner  with type  6  and  type  14  group A  hemolytic  streptococci.'
From this table it can readily be seen that the several products were fairly
uniform.  Furthermore,  these  data  correspond  fairly  well  with  some of
those obtained  by Meyer  and his collaborators  in analyzing  similar carbo-
hydrates  from  mammalian  sources  (3-5).  These  two  types  of  group  A
I The type 6 strain used was S43 and the type 14 strain was S23.  Both were obtained
originally from  the  1918 streptococcus  epidemic  in Texas  and both had been rendered
virulent  for mice by  repeated  mouse passage.
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streptococci  also  yielded  essentially  similar  products.  In  none  of  the
preparations  was  there  more  than  a  trace  of  blood  group  A substance.
We  were  unable  to remove the  ash present  in our preparations,  either  by
repeated  precipitation  with  alcohol  and  acetone  or  by prolonged  dialysis
against  distilled  water.
All  of our immunological  studies  on  the  above preparations  have  con-
firmed  the  work  of Kendall,  Heidelberger,  and  Dawson  (1),  and  of  Sea-
stone  (2),  who  were  unable  to  find  any  circulating  antibodies  in rabbits
after the injection of group A and group C streptococcal vaccines.  We have
tried many varieties of group A streptococcal  vaccines, and have employed
many different  strains.  The vaccines were killed by heat, acetic acid,  and
formalin,  respectively;  and both young and old cultures were used.  None
of these  vaccines,  nor the  prolonged  injection  of  living  cultures  intrave-
nously,  ever  gave rise  to sera  in which  even a  trace  of precipitins  for the
capsular polysaccharide occurred.  It seems therefore that Loewenthal  (12),
who  has reported  obtaining  capsular  antibodies  in rabbits, was  probably
dealing  with  some  impurity  in  his  carbohydrate  preparations,  possibly
blood  group  A  substance.
Effect of Specific Enzymes on the Capsular Polysaccharide
In order to carry out certain in vivo tests on capsules, it was necessary to
have a potent enzyme non-toxic for experimental  animals, but still capable
of splitting the  capsular  carbohydrate.  From  pneumococci,  streptococci,
Bacillus welchii  (4,  7),  and  from  soil  bacilli  (13),  carbohydrate-splitting
enzymes  have  been  isolated.  Recently,  Chain  and  Duthie  (8)  described
the presence of a similar enzyme in bovine testicular extract and they believe
that this enzyme may be the same as the spreading factor of Duran-Reynals.
Since a watery extract  of leech heads has been described as the most potent
source of  this spreading factor  (14), we decided to test the potency of such
an  extract  for  carbohydrate-splitting  enzyme.2 Leech  extract  proved  to
be  very potent  in this  respect; and furthermore, this particular  enzymatic
activity  was  confined  entirely  to  extracts  of  those  portions  of  the  leech
containing  the salivary glands.
Although  such preparations  contain  a potent  enzyme,  it was  necessary
to eliminate  the  hirudin  which occurs  in abundance  in leech  extract.  If
the hirudin were not removed,  animals treated with the extract bled easily
following injection and often succumbed to a fatal hemorrhage from a simple
hypodermic  needle  puncture.  Since  there  exist  no  definite  data  on  the
2 Recently  both  Claude  (15)  and  Meyer,  Hobby,  Chaffee,  and Dawson  (16)  have
reported the presence of a mucolytic enzyme in leech extract.
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chemical nature of hirudin,  we assumed that it might be similar  chemically
to heparin,  i.e., a high  molecular  weight polysulfuric  acid ester of  a poly-
saccharide,  and hence  we  used as a means  of getting rid of  the leech  anti-
coagulant  two  substances  which  are known  to precipitate  heparin.  With
the first of these precipitants,  clupein  (17), it was possible to remove about
85 per cent of the hirudin present in the leech extract; while with the second,
toluidine blue  (18), all but traces  of the remaining  15 per cent were precipi-
tated  and  removed.  Both  substances  were  used  in preparing  the  leech
extract described below because clupein removes other non-enzymatic mate-
rials  from  the  extract  besides  hirudin,  while  toluidine  blue  removes  the
hirudin  more  completely.
The method of preparing leech extract began essentially as described by Claude  (14):
The heads of 48 leeches were cut off just behind the salivary glands, minced with scissors
and ground with sand.  Following this, they were extracted  several  times with a total
of 50 cc. of water.  To this solution was added about 50 mg. of clupein; and the heavy
precipitate  thus  formed  was  removed  and  discarded.  At  this  point  the addition  of
more  clupein  did not  cause  further  precipitation,  although  only  85  per  cent  of  the
hirudin had been removed.  50 mg. of toluidine  blue was then added and the resulting
small  precipitate  was  removed  by  centrifugation.  The  excess  of  toluidine  blue  was
removed  by  dialysis  against  distilled  water.  During  this dialysis  another  precipitate
formed which  was also  discarded.  The  final water-clear  preparation  was  only slightly
less  potent in enzyme  than the  original extract.  It was  non-toxic  when  given intra-
peritoneally  to  mice,  and  also  contained  the  spreading  factor.  There  was  usually
about 0.5 mg. of solid material per cc. of solution.
When this leech extract was incubated with the capsular polysaccharide
under suitable conditions,  reducing groups were released.  The enzyme was
active  against  the  similar  polysaccharide  of  the  umbilical  cord  and  the
carbohydrate  obtained from a pleural tumor (3, 5).3  It was inactive against
other  polysaccharides  tried  such  as  chondroitin  sulfuric  acid  and  blood
group  A substance.  The optimum activity  was  obtained between  pH  5.0
and  6.0,  although  it  was  active  from  pH  4.5  to  9.0.  It  was  completely
inactivated  by heating at 500C. for one hour.
One peculiarity of this enzyme is that when added to its substrate, even
in  considerable  excess,  the  final  yield  of  reducing  sugar  (calculated  as
glucose)  was  only  45  to  52  per  cent, whereas  the theoretical  yield should
have been 90 per cent, assuming that the capsular  polysaccharide  is made
up  of  equivalent  amounts  of  N-acetyl  glucosamine  and  glucuronic  acid,
and  that  the  polysaccharide  was  completely  split  to  these  derivatives.
Most of the previously  described  enzymes have  split the substrate  to  the
3  These preparations  were kindly given  to us by Dr. M. H. Dawson.
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point of yielding  reducing  sugar values  close to the theoretical  90 per cent
level.  This  may  mean  that the  enzyme  in  leech  extract  is able  to split
only one of the carbohydrate linkages  and the end product is then a disac-
charide,  while  other  enzymes  or  enzyme  combinations  split  the  poly-
saccharide  down  to monosaccharide  derivatives.  Table II  shows  typical
activity figures  for the enzyme  used in various  concentrations  against the
same  amount  of  streptococcus  capsular  polysaccharide.  It  is  clear  that
even  when  the  enzyme  was  present  in  excess,  the  end  point  remained
around  50 per  cent.
TABLE II
Per Cent of Reducing Groups Released from Streptococcus Capsular Carbohydrate  by  Leech Extract
Concentration of leech  extract
Time
0.06 per cent  0.03 per cent  0.015 per cent  0.007 per cent  0.003 per cent  0.0015 percent
hrs.  per  cen  per Men  per cet  per cent  per cent  per c
1  32.2  23.5  12.7  7.5  2.5  1.0
3  42.3  43.0  36.5  29.2  18.0  13.0
7  46.5  47.2  40.0  32.0  31.5  23.3
24  50.5  52.5  47.7  48.7  47.7  39.5
The per cent concentration  of leech extract is expressed in terms of dry weight of the material
in the extract used.  Hanes' modification  of the Hagedorn-Jensen method was used for determina-
tion of  reducing  groups which are  expressed  in terms of glucose.  Corrections  have  been made
for  the proper  blanks in  each  case.  The initial  carbohydrate  concentration  in each  tube was
0.1 per cent.
Eect of Leech Extract Enzyme on Streptococcus Capsules
Many  authors have  demonstrated  the presence  of  capsules  on  group  A
streptococci  (19,  20).  One of the most satisfactory methods has been that
of Seastone,  who grew streptococci  in  high concentrations  of serum.  One
can  also  demonstrate  capsules  surrounding  microorganisms  grown  on  a
moist sealed  blood agar plate.  Although they are usually very difficult  to
detect  on  cocci  grown  in  ordinary fluid  media,  it  was  discovered  in  the
course  of another investigation  (21).that group  A  streptococci  often have
excellent  capsules  when  grown  in  Todd-Hewitt  filtered  broth.  In  such
media, the capsules  are most readily made visible by the use of moist India
ink preparations,  in which they stand out sharply against  a dark granular
background.  In Todd-Hewitt  broth cultures  of group  A streptococci,  the
capsules appear  only when the microorganisms are growing vigorously, and
they are largest  when multiplication  of the microorganisms  is most rapid.
With the slowing  of  growth, the capsules  decrease  in  size  and shortly dis-
appear,  probably  by  diffusion  into  the  medium.  Likewise  streptococci
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virulent  for  mice  are  well  encapsulated,  while  growing  in  the  peritoneal
cavity of the mouse.  On the other hand, many strains of group A strepto-
cocci,  especially  those  cultured  long  in  the  laboratory,  are  very  poorly
encapsulated  either in vivo  or in vitro.  However,  glossy  strains as well  as
matt strains may be equally well encapsulated.
Similar, but much more striking and very much larger, capsules may  be
found  on  mouse  virulent  and  guinea  pig virulent  group  C  streptococci,
grown  either  in vitro or  in vivo.  The  group  C strains  which  cause  non-
lethal endemic  infection  in guinea  pigs, usually have  small capsules,  com-
parable  in size to those of virulent group  A strains, while group  C strains
from human beings  frequently have no demonstrable  capsules at all.  The
capsules of the mouse virulent group C streptococci 4 seem much more stable
and last much longer in fluid culture than those of the group A strains.
If,  to  a  drop of  culture  of  encapsulated  streptococci  of  either  group  A
or group  C, one  adds a drop  of leech extract just before making an India
ink preparation,  the capsules disappear almost instantly.  The demonstra-
tion  works  equally  well  with  encapsulated  microorganisms  from  mouse
peritoneal  washings,  and is most striking with the virulent group  C strain
(D181)  since  the  capsules  are  so  large.  The lytic  effect  on  the  capsule
was also  demonstrable  in vivo with streptococci of either group.
Two mice  were  each  inoculated intraperitoneally  with 0.5  cc.  of culture.  One-half
hour later, one  mouse was injected intraperitoneally  with  0.1 cc.  of  leech extract.  At
30 minute intervals exudate was  removed from each  animal and mixed  with India ink.
In  the  untreated  mouse,  the  microorganisms  remained  fully capsulated,  while  in  the
one treated with enzyme, they were devoid of capsules for 2 to 4 hours, after which time
they  suddenly  became  encapsulated  (see  Figs.  1, 2, and  3).  Another  intraperitoneal
injection of  leech extract again removed them.
Effect of Leech Extract Enzyme  on Streptococcal Infections
Having  determined  that  the  enzyme  in  leech  extract  was  capable  of
acting on the capsules in vivo, the next experiment was to test the effect of
the enzyme on the course of an infection.  In Tables III and IV are recorded
the  results  with  two  group  A  strains,  D585  and  S23.  Both  strains  were
virulent  for  mice  and  both had  good  capsules.  The  mice,  divided  into
several  groups, were  inoculated  intraperitoneally  with the  indicated  dilu-
tion of culture; and then one-half  of each group received  0.1 cc. of purified
4  The mouse virulent group  C strain referred to here and used throughout  this paper
was obtained from Dr. Seastone and is referred  to in his paper  (2) as strain No. 4.  Our
designation  for this strain is D181.
6  D58 is a mouse virulent strain of a type 3 group A hemolytic streptococcus, obtained
by Colebrook  from puerperal sepsis,  and  is called by him strain "Richards."
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leech  extract  diluted  to  0.5  cc.  in saline.  The extract  was  given  intra-
peritoneally  a  few  minutes  following  the  inoculation,  then every  8  hours
TABLE  III
Protective  Action of Leech Extract  in Mice Infected with Group A Streptococcus, Type 14 (Strain  S23)
Treated with leech extract
Dilution of culture
10-
5
cc.
D1
D1
D1
D1
D2
D2
D3
D3
D4
D5
10-6 cc.
D1
D1
D1
D1
D2
D3
D10
D10
S
S
10-  cc.
D2
D3
D3
S
S
S
S
S
S
S
Virulence controls
Dilution of culture
10  cc.
D1
D1
D1
D1
D3
D3
D3
D10
S
S
10-  cc.
D1
D1
D1
D1
D1
D2
D2
D2
D3
S
10-  cc.
D1
D1
D1
S
S
S
S
S
S
S
10-8 cc.
S
S
S
S
S
S
S
S
S
S
10-o cc.
D1
DIO
S
S
S
S
S
S
S
S
All mice were inoculated first with respective dilutions of culture.  Within one-half hour after
infection,  all treated  mice  received  0.1  cc. of leech extract intraperitoneally.  The treated  mice
were then given 0.1 cc. of leech extract at 8 hour intervals for 48 hours, and at 12 hour intervals
during the 3rd and 4th days.  The experiments  shown in Tables  IV and V were done in a similar
way.
D, with a number, indicates death within that number of days.  S means survival throughout
time  of experiment,  10 days.
for 2 days, and every  12  hours on the 3rd  and  4th days.  Under the con-
ditions  of these experiments,  there  was  only  suggestive  evidence  that the
enzyme  had  a slight  influence  on  the lethal  action  of strain  S23,  in that
the  groups  of  mice  inoculated  with 10- and  10- 1 cc.  of culture survived
Mouse No.
1
2
3
4
5
6
7
8
9
10
Mouse No.
1
2
3
4
5
6
7
8
9
10
_  _
; ------------
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longer  when  treated  with  the  leech  extract,  even  though  there  was  no
significant difference in the number  of survivors.  This tendency to delayed
death  was distinctly more marked in mice inoculated with strain D58.
TABLE  IV
Protective Action of Leech Extract in Mice Infected with Group A  Streptococcus, Type 3
(D58, Strain "Richards")
Treated with leech7extract
Dilution of culture
10-G cc.
D1
D1
D1
D1
D2
D3
D3
D3
D3
S
Virulence controls
Dilution of culture
10-1  cc.
D1
D1
D1
D1
D1
D1
D1
S
S
S
See note under Table III.
When, on the other hand, a similar experiment  (Table  V) was made with
the virulent group C streptococcus,  strain D181, a marked protective influ-
ence  of  the  leech  extract  was  demonstrated.  The  enzyme  protected  the
mice  completely  up to and including  10,000  M.L.D.'S,  which was the maxi-
mum employed.  When still another group of controls was treated with the
same  leech  extract,  which  had  been  inactivated  by heating  at  500C.  for
40  minutes,  it  no  longer  offered  protection,  showing  that  the  protective
105 cc.
D1
D2
D2
D2
D3
D3
D4
D4
S
S
10-1 cc.
D2
D2
D4
D4
S
S
S
S
S
S
10-8 cc.
D1
D1
D2
D4
D7
S
S
S
S
S
Mouse No.
1
2
3
4
5
6
7
8
9
10
Mouse  No.
1
2
3
4
5
6
7
8
9
10
10-5 cc.
D1
D1
D1
D1
D1
D1
D1
D1
D1
S
10-7 cc.
D1
D1
D1
S
S
S
S
S
S
S
10-8 cc.
D1
D1
D1
D1
S
S
S
S
S
S
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factor  has  about  the  same  heat  lability  as  the  carbohydrate-splitting
enzyme.  If  the  animals  receiving  the  active  enzyme  were  not  treated
intensively  following  infection,  the  amount  of  protection  was  much  less;
and  even  those  treated  effectively  for  4  days  occasionally  suffered  recur-
rences and died 4 to 8 days after the treatment  was discontinued.
TABLE  V
Protective  Action of Leech Extract in Mice Infected with Group C Streptococcus Strain (D181)
Treated with leech  extract
Dilution of culture
10  cc.  101 cc.  10-4 cc.  10-1. 
S  S  S  S
S  S  S  S
S  S  S  S
S  S  S  S
10  cc.
S
S
S
S
Treated with leech  extract heated  (560  40 minutes)
Dilution of culture
10-  cc.  10-  cc.  10-4 cc.  10-  cc.  0  cc.  10-7  cc.
D1  D1  D2  D2  D2  S
D1  D1  D2  D2  D2  S
D1  D2  D2  D2  D2  S
D2  D2  D2  D4  S  S
Virulence  controls
Dilution of culture
10-  cc.  10  cc.  10-
4 cc.  10-s cc.  10-  cc.  10-7 cc.
D1  D1  D2  D2  D2  S
D1  D1  D2  D2  D2  S
D1  D2  D2  D2  D2  S
D2  D2  D2  D3  D2  S
In this experiment  the mice were treated  for 4 days and the experiment was  terminated on
the 6th day.  See note under  Table III.
A similar  experiment  was  carried  out in  guinea pigs,  since  they are  the
natural hosts of this infectious agent.  In this experiment,  summarized in
Table VI, the guinea pigs were infected intraperitoneally with graded  doses
of the same group C strain used in mice.  The controls died in  1 to 6 days,
all having peritonitis and blood stream  invasion.  The treated  guinea pigs
were given 0.3 cc. of leech extract intraperitoneally every 8 hours for 3 days
and  every  12  hours  for  3 additional  days,  beginning a  few  minutes  after
I
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inoculation.  All  the  treated  guinea  pigs were  sacrificed  at the  end  of  a
week;  and cultures  of  the blood,  abdominal abscesses,  and  peritoneal sur-
face were made.  In no case was there any peritonitis or peritoneal abscess.
The  four  guinea  pigs  receiving  the  highest  doses  of  inoculum  had  sub-
cutaneous abscesses and varying degrees of bacteremia, while in the remain-
ing  two,  no  evidence  of  infection  was  found.  Since  the  control  animals
all died of peritonitis,  while the treated ones had none,  it seems plain  that
the extract was able to control this phase of  the infection.  Those  guinea
TABLE  VI
Protective  Action of Leech Extract in Guinea Pigs  Infected with Group C Streptococcus, Strain D181
Infecting  dose
10-1 cc.  10-2 cc.  I  cc.  10-  cc.  10  I-  cc.  {  101 cc.
Treated
S  S  S  S  S  S
Blood culture  +  +++  ++++  ++  - -
Peritoneal culture  _  _ 
Skin abscess culture  ++ +  ++  +  + ++ +  +  ++  No abscess  No abscess
Controls
Dl  D6  D2  D2  D5  D2
Blood  culture  ++++  ±+++  +  -++  +++  ++++  ++++
Peritoneal  culture  ++++  ++++  ++++  +++  +  ++++  ++++
Treatment  was started within 30 minutes after  the infecting  dose had been given.  Treated
guinea  pigs received  0.3  cc.  of  leech extract,  intraperitoneally,  every  8 hours  for 72  hours, and
every  12 hours thereafter,  until the experiment  was terminated  at one week.  See Table III for
further  explanation.
pigs  that had  the  abscesses  and  blood  stream  infection,  probably  would
have  eventually  succumbed  even  had  the  treatment  been  continued.
Doubtless,  these animals received a small subcutaneous infection along the
tract of the needle used for  intraperitoneal inoculation;  and it seems likely
that the enzyme preparation  had little or no  effect on the infection  in this
site, and from this abscess the organisms were able to multiply and invade
the  blood  stream.
DISCUSSION
The capsule of group A and group C streptococci  does not seem to be an
organized structure in the same sense that a cell wall is a structure.  Rather
it  seems to be  merely an accretion  around  the microorganism  of  a slowly
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diffusible  substance,  which  during the  active phase  of bacterial growth  is
produced  faster than it diffuses away.  The capacity to produce  this cap-
sular substance varies enormously among the different strains, but is always
well  developed  in  mouse  virulent  strains  of both  groups  of  streptococci;
and in some mouse virulent group  C strains its production  is very marked.
Seastone  (2)  has presented  evidence  indicating  that the  large  capsules
of virulent group C strains are responsible  in part for their increased viru-
lence.  In his infected  colony  of guinea  pigs,  the  endemic microorganism
was  a group  C streptococcus  which had the power  of infecting the animals
without killing them; and the infection remained localized in lymph nodes.
When,  however, a virulent group C strain appeared  in the colony, probably
by variation  of the  endemic  strain,  it killed  large  numbers  of  the  guinea
pig population with  an acute  disease.  This new  strain  was always  much
more  heavily capsulated  than the endemic  strain.  Seastone  tried in  vain
to protect animals against this virulent infection, both by active and passive
immunization;  but only in those animals having chronic infection with the
endemic strain was any protection observed,  and even here was very slight.
In our experiments  with  group  C  streptococcal  infections of both  mice
and guinea pigs, we obtained good protection by the use of an enzyme which
would effectively  remove these large capsules, and it seems at least possible
that  the  saccharolytic  and  protective  agent  are  the  same.  This  offers
further substantial  evidence that the capsule of these group C streptococci
is an important  factor in making these strains virulent for mice and guinea
pigs.  This in vivo demonstration of the effect of the enzyme on the capsule
was  limited in these experiments  to peritoneal  infections,  where  the infec-
tious process  was  so  circumscribed  that the  microorganisms  were  readily
accessible  to the therapeutic  agent.  The  presence of the spreading factor
in these  leech extracts made it impossible to show a similar effect  on sub-
cutaneous  infections,  since  the  spreading  factor,  if  applied  there,  would
probably have extended the local area of infection.  The fact that repeated
intraperitoneal  administration  of the  enzyme  is  necessary  for protection,
and  that  a  demonstrable  decapsulating  effect  lasts  only  a  few  hours  is
probably due to inactivation of the active principle, possibly by exhaustion
on a  similar substrate in the host.
With  group  A  streptococci,  the  story  is  somewhat  different.  In  this
group  we have  never encountered  a strain which  has capsules  comparable
in  size  to the  virulent  group  C  strain.  While  there  is  some  parallelism
between the appearance  of mucoid colonies  and virulence  of many strains
of group A, nevertheless,  the importance  of another factor associated  with
virulence,  the M  substance,  has been  amply demonstrated  (22).  The  M
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substance  is always  present in mouse  virulent  strains;  and sera containing
sufficient  anti-M  antibody has a marked protective effect  against group A
streptococcus  infection  of  mice.  From  the  results  of  the present  experi-
ments,  it would seem  that the  capsule  plays a minor rle in the virulence
and invasiveness  of these particular microorganisms.  Here again it seems
unwise  to generalize  from the very special type of infection where bacteria
are  put  into  the  peritoneal  cavity  of  the  mouse  and  the  decapsulating
enzyme  is applied  at the same site,  to  instances  where  the infection  is  in
other  tissues  in which it is impossible  to bring  the enzyme  so  closely into
contact  with the microorganism.
SUMMARY
1. Confirming  the observations of other experimenters, it has been found
that  group  A hemolytic  streptococci  produce  a capsule containing  a poly-
saccharide  which is similar  to, if not identical with, certain high molecular
weight  sugars  found  in the  mammalian  body.
2.  Leech  extract  possesses  a  powerful  enzyme  capable  of  splitting  one
of  the  linkages  in  this  polysaccharide  and  of  decapsulating  group  A  and
group  C  hemolytic streptococci  in vitro and in vivo.
3.  Mice and guinea pigs can be protected  from intraperitoneal  infection
with a virulent group C streptococcus by the intraperitoneal administration
of leech extract.  In contrast there is little protective action of leech extract
in mice infected  with group A hemolytic  streptococci.
4.  The  protective  effect  of  leech extract  against  streptococcal  group  C
infection  is probably  due to the removal of  the capsule in vivo.
5.  The capsule of mouse virulent group C  streptococci plays a major rle
in  the virulence  of  that microorganism,  while the  capsule of  certain mouse
virulent group A  streptococci plays little, if any, r6le in virulence,  at least
when the infection  is intraperitoneal  in the mouse.
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EXPLANATION  OF  PLATE  26
FIG.  1.  Capsule  on group  A  hemolytic  streptococci  (strain  S23),  grown  in  mouse
peritoneum.  India ink preparation.  X  1,000.
FIG.  2.  Capsule on group  C  hemolytic  streptococci  (strain  D181),  grown  in mouse
peritoneum.  India ink preparation.  X  1,000.
FIG. 3.  Decapsulated  group C hemolytic streptococci  (strain D181),  grown in mouse
peritoneum,  and withdrawn  30 minutes  after intraperitoneal  injection of leech extract.
India  ink preparation.  X  1,000.
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PLATE 26